Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2008-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1167/iovs.08-1849PMID 18566467PMCID PMC3947384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Local neuroinflammation and the progression of Alzheimer’s disease

  2011cited by this paper
• Retinal nerve fiber layer abnormalities in Alzheimer's disease.

  2009cited by this paper
• Complement-associated deposits in the human retina.

  2008cited by this paper
• Retinal tau pathology in human glaucomas.

  2008cited by this paper
• Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model.

  2008cited by this paper
• Inflammatory processes in Alzheimer's disease.

  2007cited by this paper
• Retinal abnormalities in early Alzheimer's disease.

  2007cited by this paper
• Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease.

  2007cited by this paper
• Distinct distal regulatory elements control tyrosinase expression in melanocytes and the retinal pigment epithelium.

  2007cited by this paper
• Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA/2J glaucomatous mouse retinas.

  2007cited by this paper
• Targeting amyloid-beta in glaucoma treatment.

  2007cited by this paper
• Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging

  2006cited by this paper
• Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

  2006cited by this paper
• Relationship between Cognitive Impairment and Retinal Morphological and Visual Functional Abnormalities in Alzheimer Disease

  2006cited by this paper
• Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid

  2006cited by this paper
• Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers.

  2006cited by this paper
• Microglia and macrophages are increased in response to ischemia-induced retinopathy in the mouse retina.

  2006cited by this paper
• Complement Factor H Polymorphism in Age-Related Macular Degeneration

  2005cited by this paper
• Complement Factor H Polymorphism and Age-Related Macular Degeneration

  2005cited by this paper
• A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.

  2005cited by this paper
• Synaptic pathology, altered gene expression, and degeneration in photoreceptors impacted by drusen.

  2005cited by this paper
• Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration

  2005cited by this paper
• Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration.

  2004cited by this paper
• Characterization of β amyloid assemblies in drusen: The deposits associated with aging and age-related macular degeneration

  2004cited by this paper
• Glaucoma: ocular Alzheimer's disease?

  2003cited by this paper
• Apolipoprotein E Markedly Facilitates Age-Dependent Cerebral Amyloid Angiopathy and Spontaneous Hemorrhage in Amyloid Precursor Protein Transgenic Mice

  2003cited by this paper
• Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas.

  2003cited by this paper
• An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice

  2003cited by this paper
• Role of MCP‐1 and MIP‐1α in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization

  2003cited by this paper
• Drusen proteome analysis: An approach to the etiology of age-related macular degeneration

  2002cited by this paper
• The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration

  2002cited by this paper
• The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease.

  2002cited by this paper
• Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension.

  2002cited by this paper
• The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration.

  2002cited by this paper
• The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease

  2002cited by this paper
• Morphological and functional retinal impairment in Alzheimer's disease patients.

  2001cited by this paper
• Co-expression of multiple transgenes in mouse CNS: a comparison of strategies.

  2001cited by this paper
• An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration.

  2001cited by this paper
• Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation.

  2000cited by this paper
• Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo.

  1998cited by this paper
• Soluble Alzheimers β-amyloid constricts the cerebral vasculature in vivo

  1998cited by this paper
• Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

  1998cited by this paper
• Optometric management of patients with Alzheimer's disease.

  1997cited by this paper
• Syrian hamster prion protein (PrP(C)) is expressed in photoreceptor cells of the adult retina.

  1997cited by this paper
• Optometric management of patients with Alzheimer's disease.

  1997cited by this paper
• Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina.

  1996cited by this paper
• Brain Parenchymal and Microvascular Amyloid in Alzheimer's Disease

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

  1996cited by this paper
• Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL.

  1996cited by this paper
• Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

  1995cited by this paper
• Retinal ganglion cells in Alzheimer's disease and aging

  1993cited by this paper
• Complement activation by beta-amyloid in Alzheimer disease.

  1992cited by this paper
• Optic nerve head and nerve fiber layer in Alzheimer's disease.

  1991cited by this paper
• Retinal Degeneration in the Macula of Patients with Alzheimer's Disease a

  1991cited by this paper
• Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group.

  1990cited by this paper
• Abnormal pattern electroretinogram in Alzheimer's disease: Evidence for retinal ganglion cell degeneration?

  1989cited by this paper
• Abnormal pattern electroretinograms in patients with senile dementia of the alzheimer type

  1989cited by this paper
• Assessment of visual impairment in patients with Alzheimer's disease.

  1987cited by this paper
• Optic-nerve degeneration in Alzheimer's disease.

  1986cited by this paper

• Morpho-Functional Characterization and miRNA Profiling of the Retina in the 5xFAD Murine Model of Alzheimer's Disease

  2026cites this paper
• Early and progressive retinal microglial changes in APPNL-F/NL-F mouse model of Alzheimer’s disease revealed by an automated image analysis software

  2026cites this paper
• Evaluating causal links between retinal thickness, Alzheimer's disease, and circulating total-tau: evidence from Mendelian randomization and colocalization analysis.

  2026cites this paper
• Retained introns in phototransduction genes of 5xFAD mouse retina suggest vision impairment as an early diagnostic marker for Alzheimer’s disease

  2025cites this paper
• Choroidal evaluation of FTLD-Tau and biomarker-determined Alzheimer’s disease

  2025cites this paper
• Three-Dimensional β-Amyloid Burden Correlation Between the Eye and Brain in Alzheimer's Disease Mice Using Light-Sheet Fluorescence Microscopy

  2025cites this paper
• Klotho null mutation leads to retinal degeneration characterized by functional impairment, gliosis, and deposition of amyloid-beta and hyperphosphorylated tau proteins

  2025cites this paper
• Diabetic retinopathy and Alzheimer's disease: Convergence of the unfolded protein response in neurodegeneration

  2025cites this paper
• Advanced understanding of the neurotoxicity of brominated flame retardants: Integrating human neural organoids with multi-omics.

  2025cites this paper
• Retinal Neurovascular Coupling: From Mechanisms to a Diagnostic Window into Brain Disorders

  2025cites this paper
• Choroidal and retinal vascular changes in adults with Down syndrome: Insights into the Alzheimer's disease continuum

  2025cites this paper
• Exploring Retinal Neurodegeneration in Alzheimer’s Disease: A Molecular and Cellular Perspective

  2025cites this paper
• Retinal microvascular alterations in motoric cognitive risk syndrome: an OCT angiography study

  2025cites this paper
• Recent Advances in Visual Dysfunction and Ocular Biomarkers in Neurological Disorders

  2025cites this paper
• Neurodegenerative biomarkers in different chambers of the eye relative to plasma: an agreement validation study

  2024cites this paper
• Retinoic acid related orphan receptor α is a genetic modifier that rescues retinal degeneration in a mouse model of Stargardt disease and Dry AMD

  2024cites this paper
• Imaging the eye as a window to brain health: frontier approaches and future directions

  2024cites this paper
• Targeting shared pathways in tauopathies and age-related macular degeneration: implications for novel therapies

  2024cites this paper
• Eucalyptol Ameliorates Retinal Microvascular Defects through Modulating ER Stress and Angiopoietin–Tie Signaling in Diabetic Eyes

  2024cites this paper
• Alzheimer's Disease Pathophysiology in the Retina.

  2024cites this paper
• Aging-associated sensory decline and Alzheimer’s disease

  2024cites this paper
• Alterations in zinc, copper, and iron levels in the retina and brain of Alzheimer's disease patients and the APP/PS1 mouse model

  2024cites this paper
• Single-cell transcriptome profiling highlights the role of APP in blood vessels in assessing the risk of patients with proliferative diabetic retinopathy developing Alzheimer’s disease

  2024cites this paper
• Serum Oxidative Stress-related Biomarkers in Ocular Hypertension and Glaucoma

  2024cites this paper
• Natural compounds efficacy in Ophthalmic Diseases: A new twist impacting ferroptosis.

  2024cites this paper
• Hyperspectral retinal imaging in Alzheimer’s disease and age-related macular degeneration: a review

  2024cites this paper
• Association of lamina cribrosa thickness and hippocampal volume in Alzheimer's disease patients

  2024cites this paper
• Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease

  2024cites this paper
• Retinal imaging biomarkers of Alzheimer's disease: A systematic review and meta‐analysis of studies using brain amyloid beta status for case definition

  2023cites this paper
• The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain.

  2023cites this paper
• Retinal inner nuclear layer thickness in the diagnosis of cognitive impairment explored using a C57BL/6J mouse model

  2023cites this paper
• Ergothioneine, a dietary antioxidant improves amyloid beta clearance in the neuroretina of a mouse model of Alzheimer’s disease

  2023cites this paper
• MicroRNAs in tear fluids predict underlying molecular changes associated with Alzheimer’s disease

  2023cites this paper
• Artificial intelligence in the diagnosis of glaucoma and neurodegenerative diseases

  2023cites this paper
• MicroRNAs in tear fl uids predict underlying molecular changes associated with Alzheimer ’ s disease

  2023cites this paper
• Glaucoma as a Tauopathy—Is It the Missing Piece in the Glaucoma Puzzle?

  2023cites this paper
• Salvianolic acid B ameliorates retinal deficits in an early-stage Alzheimer’s disease mouse model through downregulating BACE1 and Aβ generation

  2023cites this paper
• Retinal Alterations as Potential Biomarkers of Structural Brain Changes in Alzheimer’s Disease Spectrum Patients

  2023cites this paper
• Ferroptosis: mechanisms and advances in ocular diseases

  2023cites this paper
• Differential reductions in the capillary red-blood-cell flux between retina and brain under chronic global hypoperfusion

  2023cites this paper
• Altered Clock Gene Expression in Female APP/PS1 Mice and Aquaporin-Dependent Amyloid Accumulation in the Retina

  2023cites this paper
• Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions

  2023cites this paper
• Amyloid-beta and tau protein beyond Alzheimer’s disease

  2023cites this paper
• Advances in transcorneal electrical stimulation: From the eye to the brain

  2023cites this paper
• Clearance of interstitial fluid (ISF) and CSF (CLIC) group‐part of Vascular Professional Interest Area (PIA), updates in 2022‐2023. Cerebrovascular disease and the failure of elimination of Amyloid‐β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy

  2023cites this paper
• Retinal arterial Aβ40 deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients

  2023cites this paper
• Morphological and biomolecular targets in retina and vitreous from Reelin-deficient mice (Reeler): Potential implications for age-related macular degeneration in Alzheimer’s dementia

  2022cites this paper
• The retina: A window in which to view the pathogenesis of Alzheimer's disease.

  2022influential citation
• Alzheimer’s disease amyloid-β pathology in the lens of the eye

  2022cites this paper
• Alzheimer’s Disease Seen through the Eye: Ocular Alterations and Neurodegeneration

  2022cites this paper
• Retinal Examinations Provides Early Warning of Alzheimer’s Disease

  2022cites this paper
• Cognitive dysfunctions in high myopia: An overview of potential neural morpho-functional mechanisms

  2022cites this paper
• Coffee: Health effects and various disease treatments

  2022cites this paper
• Risk of retinal disease in patients with bipolar disorder: A nationwide cohort study

  2022cites this paper
• Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer’s-induced retinal vasculopathy by limiting Clec7a/Galectin-3+ neurodegenerative microglia

  2022cites this paper
• Retinal Microvascular Changes in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review, Meta-Analysis, and Meta-Regression

  2022cites this paper
• Choroid and choriocapillaris changes in early-stage Parkinson’s disease: a swept-source optical coherence tomography angiography-based cross-sectional study

  2022cites this paper
• Research progress of ferroptosis in glaucoma and optic nerve damage

  2022cites this paper
• Differentiation of brain and retinal organoids from confluent cultures of pluripotent stem cells connected by nerve-like axonal projections of optic origin

  2022cites this paper
• Concomitant Retinal Alterations in Neuronal Activity and TNFα Pathway Are Detectable during the Pre-Symptomatic Stage in a Mouse Model of Alzheimer’s Disease

  2022cites this paper
• Association of Inner Retinal Thickness with Prevalent Dementia and Brain Atrophy in a General Older Population

  2022cites this paper
• The Small Molecule GAL-201 Efficiently Detoxifies Soluble Amyloid β Oligomers: New Approach towards Oral Disease-Modifying Treatment of Alzheimer’s Disease

  2022cites this paper
• Molecular Mechanisms of Iron Mediated Programmed Cell Death and Its Roles in Eye Diseases

  2022cites this paper
• Brain and Retinal Organoids for Disease Modeling: The Importance of In Vitro Blood–Brain and Retinal Barriers Studies

  2022cites this paper
• The relationship between retinal layers and brain areas in asymptomatic first-degree relatives of sporadic forms of Alzheimer’s disease: an exploratory analysis

  2022cites this paper
• Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer’s Disease Are Linked with Neurotransmitter Alterations

  2021cites this paper
• Retinal Changes in Transgenic Mouse Models of Alzheimer's Disease.

  2021cites this paper
• Systemic delivery of a specific antibody targeting the pathological N-terminal truncated tau peptide reduces retinal degeneration in a mouse model of Alzheimer’s Disease

  2021cites this paper
• Inhalable Thioflavin S for the Detection of Amyloid Beta Deposits in the Retina

  2021cites this paper
• Downregulation of Circular RNA PSEN1 ameliorates ferroptosis of the high glucose treated retinal pigment epithelial cells via miR-200b-3p/cofilin-2 axis

  2021cites this paper
• Visual-stimuli Four-arm Maze test to Assess Cognition and Vision in Mice.

  2021cites this paper
• Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer’s Disease

  2021cites this paper
• Retinal Thickness Changes Over Time in a Murine AD Model APPNL-F/NL-F

  2021cites this paper
• Age dependence of retinal vascular plexus attenuation in the triple transgenic mouse model of Alzheimer's disease.

  2021cites this paper
• Cognitive Dysfunctions in Glaucoma: An Overview of Morpho-Functional Mechanisms and the Impact on Higher-Order Visual Function

  2021cites this paper
• Traumatic Brain Injury Exacerbates Alzheimer’s Disease Pathology in the Retinas of TgF344-AD Rats

  2021cites this paper
• Retinal hyperspectral imaging in the 5xFAD mouse model of Alzheimer’s disease

  2021cites this paper
• Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease a systematic review.

  2021cites this paper
• Retinal Dysfunction in Alzheimer’s Disease and Implications for Biomarkers

  2021influential citation
• Myeloid cells in retinal and brain degeneration

  2021cites this paper
• Progressive impairments in executive function in the APP/PS1 model of Alzheimer's disease as measured by translatable touchscreen testing.

  2021cites this paper
• Retinal imaging in Alzheimer’s disease

  2021cites this paper
• Differentiation of cortical brain organoids and optic nerve-like structures from retinal confluent cultures of pluripotent stem cells

  2021cites this paper
• Touchscreen Cognitive testing: Cross-Species Translation and Co-Clinical Trials in Neurodegenerative and Neuropsychiatric Disease.

  2021cites this paper
• Retinal Amyloid Imaging for Screening Alzheimer’s Disease

  2021cites this paper
• Color and contrast vision in mouse models of aging and Alzheimer’s disease using a novel visual-stimuli four-arm maze

  2021cites this paper
• Protein and Imaging Biomarkers in the Eye for Early Detection of Alzheimer’s Disease

  2021cites this paper
• Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline.

  2021cites this paper
• Retinal involvement in Alzheimer's disease (AD): evidence and current progress on the non-invasive diagnosis and monitoring of AD-related pathology using the eye

  2020cites this paper
• Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer’s Disease

  2020influential citation
• Optical Coherence Tomography in Alzheimer’s Disease

  2020cites this paper
• The AppNL-G-F mouse retina is a site for preclinical Alzheimer’s disease diagnosis and research

  2020cites this paper
• Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances.

  2020cites this paper
• Amyloid Beta Immunoreactivity in the Retinal Ganglion Cell Layer of the Alzheimer’s Eye

  2020cites this paper
• Molecular Imaging of Fluorinated Probes for Tau Protein and Amyloid-β Detection

  2020cites this paper
• Interactions between Amyloid-Β Proteins and Human Brain Pericytes: Implications for the Pathobiology of Alzheimer’s Disease

  2020cites this paper
• Ocular Vascular Changes in Mild Alzheimer’s Disease Patients: Foveal Avascular Zone, Choroidal Thickness, and ONH Hemoglobin Analysis

  2020cites this paper
• Advances in Retinal Imaging: Retinal Amyloid Imaging

  2020cites this paper
• Ganglion Cell Layer Thinning in Alzheimer’s Disease

  2020cites this paper
• Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease

  2020cites this paper